Clinical Trials Logo

Perioperative Care clinical trials

View clinical trials related to Perioperative Care.

Filter by:

NCT ID: NCT03553667 Not yet recruiting - Perioperative Care Clinical Trials

Using the "Edwards" EV1000 Clinical Platform NI in Lymphatic Venous Anastomosis

Start date: June 10, 2018
Phase: N/A
Study type: Interventional

Lymphatic venous anastomosis could be applied on patients suffering from limb lymphedema after surgery or radiotherapy. The particular pathophysiology leads unconventional fluid treatment strategy and changes in urine output. Hemodynamic monitors shows the benefits in perianesthetic care in fluid maintenance and decrease postanesthetic complication. Invasive hemodynamic monitors, such as arterial line and FlowTrac, have risks of hematoma, infection, nerve injury in puncture site. In this study, photoplethysmography is applied comparing with conventional mean arterial pressure for perianesthetic hemodynamic optimization in bispectral index (BIS)-guided target-controlled infusion sedation on lymphatic venous anastomosis.

NCT ID: NCT03422120 Completed - Colorectal Cancer Clinical Trials

Human Blood Specimen Collection to Evaluate Immune Cell Function

Start date: August 1, 2016
Phase:
Study type: Observational

Natural killer (NK) cells are leukocytes of the innate immune system and play a central role in the control of cancer metastases. NK cells and other innate immune cells often do not function well in patients with cancer and are also profoundly suppressed after cancer surgery. Dr. Auer's Lab and others have shown that NK cells are critically important in the clearance of tumor metastases and that their impairment can be recovered with immune therapy augmenting the innate immune system. Several studies suggest that cancer patients have depressed NK cell cytotoxicity as compared to healthy controls but that following resection of the cancer, NK cell cytotoxicity returns to normal levels. In this observational study, the investigators will measure NK cell cytotoxicity by the gold standard method (51Cr, a chromium51 release assay) and by a new interferon-ɣ (IFN-ɣ) based assay (NK-Vue™) in healthy humans and colorectal cancer (CRC) surgery patients seen a The Ottawa Hospital. The results of this study will determine if the NK-Vue™ is able to discriminate between healthy human volunteers and newly diagnosed cancer patients and is sufficiently sensitive to detect transient NK cell suppression immediately following surgery.

NCT ID: NCT03328039 Completed - Perioperative Care Clinical Trials

uSing Wearable TEchnology to Predict Perioperative High-riSk Patient Outcomes

STEPS
Start date: February 1, 2017
Phase:
Study type: Observational

This is an observational, non-interventional study to assess the equivalence of wearable monitors with formal CPET testing for the prediction of physiological reserve before major surgery.

NCT ID: NCT03325413 Completed - Perioperative Care Clinical Trials

Improvement of Perioperative Care of Elderly Patients

PeriAge
Start date: November 1, 2017
Phase: N/A
Study type: Interventional

The focus of this study is the development of a perioperative treatment concept for elderly patients, based on individual necessities and risk factors, aiming to improve patient outcome. The planned interventions include preoperative screening for malnutrition, frailty and uncalled-for long-term medication, if required followed by early prophylaxis and treatment of these risk factors, prior to or during surgery.

NCT ID: NCT03308071 Completed - Postoperative Pain Clinical Trials

Hypnosis for Symptom Management in Elective Orthopedic Surgery

Start date: September 20, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if teaching self-hypnosis techniques to patients prior to knee replacement surgery will decrease their pain medication requirements, pain medication side-effects, length of stay in the hospital, readmission rates, pain, anxiety, physical function, satisfaction scores, and cost of admission.

NCT ID: NCT03189550 Completed - Colorectal Surgery Clinical Trials

Enhanced Recovery After Surgery in Colorectal Surgery: A Large-Scale Quality Improvement Project

ERAS
Start date: July 1, 2014
Phase:
Study type: Observational

Multimodal perioperative care pathways have evolved into enhanced recovery after surgery (ERAS). ERAS pathways improve the quality of patient care, reduce morbidity, and shorten length of stay. This project will test the hypothesis that implementation of a multi-modal ERAS perioperative care protocol in colorectal surgical patients will result in significantly reduced perioperative morbidity and mortality.

NCT ID: NCT03111875 Completed - Clinical trials for Surgery--Complications

Perioperative Hypothermia and Myocardial Injury After Non-cardiac Surgery

PROTECT
Start date: March 27, 2017
Phase: N/A
Study type: Interventional

We propose to test the hypothesis that aggressive warming reduces the incidence of major cardiovascular complications, compared to routine care. Half of the participants will be randomly assigned to routine care (core temperature ≈35.5°C), while the other half will receive aggressive warming (>37°C core temperature) in a multi-center trial.

NCT ID: NCT03012802 Completed - Clinical trials for Postoperative Complications

Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol

POWER
Start date: September 15, 2017
Phase:
Study type: Observational [Patient Registry]

Short title POWER Audit Methods 60 days national (Spain) audit of postoperative complications following elective gastrointestinal surgery within an enhanced recovery after surgery (ERAS) protocol. Research sites Hospitals undertaking elective lower gastrointestinal surgery. Objective To provide detailed data describing post-operative complications and associated mortality; and length of stay. To provide detailed data describing adherence to ERAS protocol and its association to morbidity. Number of patients Not specified. All eligible patients undergoing surgery during the study month. Inclusion Criteria All adult patients (aged ≥18 years) undergoing lower gastrointestinal elective surgery within an ERAS protocol during the 60 day study period. Statistical analysis Univariate analysis will be used to test factors (patient, surgical, and ERAS related) associated with surgical complications, length of stay (LOS) and in-hospital death. Single and multi-level logistic regression models will be constructed to identify factors independently associated with these outcomes and to adjust for differences in confounding factors. A stepwise approach will be used to enter new terms. A single final analysis is planned at the end of the study. Summary statistics with post hoc Bonferroni corrections will be used to assess possible dose-response dependence in percentage of patients with postoperative complications and LOS. Proposed Start Date A 60 day period between 2017 Proposed End Date Data collection will end by September 2017 Study Duration Six months

NCT ID: NCT02768610 Completed - Perioperative Care Clinical Trials

Use of Preanesthetic Dexmedetomidine in Elderly, Treated-hypertensive Patients

Start date: March 2016
Phase: Phase 4
Study type: Interventional

Background: Dexmedetomidine is an alpha 2 adrenergic agonist with sedative, anxiolytic, and analgesic properties. This study was designed to evaluate the inhibitory effects of preoperative 0.5 μg/kg dexmedetomidine on hemodynamic responses caused by endotracheal intubation in elderly patients being treated for hypertension. Methods: Forty elderly (≥ 65 years) treated-hypertensive patients of American Society of Anesthesiologists physical status II undergoing elective noncardiac surgery were randomly and assigned to two groups. Group C received normal saline and group D received 0.5 μg/kg dexmedetomidine intravenously over 10 min just before endotracheal intubation. Systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) and heart rate (HR) were recorded preoperatively at ward, immediately after study drug administration, and at 1, 3, and 5 minutes after endotracheal intubation.

NCT ID: NCT02580214 Completed - Perioperative Care Clinical Trials

Immunonutrition in Total Hip Arthroplasty

Immunehip
Start date: May 2013
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this pilot study was to investigate whether the use of a multimodal protocol of preoperative care plus preoperative immune nutrition would decrease the length of stay and acute phase inflammation in patients submitted to total hip arthroplasty (THA). The study was designed to be randomized and controlled, but not double blind. The patients were randomized to receive either preoperative care based on evidence plus immune nutrition for 5 days prior to surgery (Acerto group) or traditional preoperative care (control group). Main endpoints were length of stay and acute-phase postoperative response